Independent public reference library

Ageing biology, biomarkers, interventions, and research literacy.

Frailty Phenotype vs Frailty Index

Key Takeaways

Frailty is widely used to describe reduced reserve and increased vulnerability to stressors in later life, but two models dominate the literature. The frailty phenotype treats frailty as a recognizable clinical syndrome, while the frailty index treats it as a graded accumulation of deficits across body systems and functional domains. [1] [2]

Who This Is Useful For

This page is useful for readers comparing research papers that use different frailty measures. It is especially relevant when a study reports frailty prevalence, mortality prediction, intervention response, or biological ageing associations without making clear which operational definition was used. [5] [8] [9]

Two Models, Two Questions

The phenotype model asks whether a person expresses a specific cluster of physical signs associated with frailty. The deficit-accumulation model asks how many health problems have accumulated relative to the number assessed. These are related but not identical questions, so agreement between the two tools is often incomplete even when both predict risk. [1] [2] [7]

Comparison at a Glance

Dimension Frailty Phenotype Frailty Index
Core idea A physical syndrome with defined observable criteria [1] A continuous measure of accumulated age-related deficits [2]
Typical inputs Weight loss, grip strength, exhaustion, gait speed, physical activity [1] Symptoms, diagnoses, disability, cognition, mood, function, and laboratory or clinical variables [3]
Score format Usually robust, pre-frail, or frail based on number of criteria [1] Usually a ratio from 0 to 1 based on deficits present divided by deficits measured [3]
Main strength Concrete physical construct that is easy to explain [1] Broad risk gradient that can use many routinely collected variables [4]
Main limitation May miss cognitive, social, disease, and disability burden outside the physical syndrome [7] Can be data-intensive and less intuitive because the included deficits vary by dataset [3] [9]

Frailty Phenotype

The original phenotype model was developed in the Cardiovascular Health Study and defines frailty by five criteria: unintentional weight loss, weakness, self-reported exhaustion, slow walking speed, and low physical activity. People meeting three or more criteria are typically classified as frail, while those meeting one or two criteria are often classified as pre-frail. [1]

Its strength is conceptual clarity. The phenotype focuses on a physical frailty syndrome involving energy balance, strength, mobility, and endurance. Its limitation is that modified versions are common, and changes to cut-points, measurement tools, or available variables can alter classification and predictive performance across studies. [5]

Frailty Index

The frailty index comes from the deficit-accumulation model. A deficit can be a symptom, sign, disease, impairment, disability, or laboratory abnormality that becomes more common with age and is associated with health status. The score is calculated as the number of deficits present divided by the total number considered. [2] [3]

Its strength is breadth. A well-constructed index can summarize multisystem burden and generate a continuous risk gradient. Its limitation is that the meaning of a score depends on how the index was built, including which deficits were available, how missing data were handled, and whether enough deficits were included to produce a stable estimate. [3] [4]

Prediction and Classification

Both models predict adverse outcomes, including mortality and disability, but they do not always identify the same people as frail. A person with slow gait and weakness may meet phenotype criteria with relatively few diagnoses, while another person with multiple diseases and impairments may have a high frailty index without expressing the full physical phenotype. [6] [7] [8]

Systematic review evidence suggests that, when compared in the same community-dwelling populations, the frailty index and frailty phenotype have modest and broadly comparable ability to predict all-cause mortality. Continuous scoring tends to preserve more information than categorical classification for either approach. [8]

Why Prevalence Estimates Differ

Frailty prevalence depends strongly on the instrument used. The phenotype can produce lower or more specific estimates when the required physical criteria are strictly measured. A frailty index may classify more people along a broader continuum because it incorporates disease burden, functional limitations, cognition, mood, and other deficits. Cross-study comparisons are therefore difficult unless the operational definition is specified. [4] [5] [9]

Evidence Quality and Interpretation

Confidence is strong that both models capture clinically meaningful vulnerability and predict adverse outcomes in older populations. The phenotype and index have each been repeatedly validated, and their continued use reflects complementary strengths rather than a simple winner-takes-all comparison. [1] [6] [8]

Confidence is weaker for claims that a result using one model automatically translates to the other. Because the phenotype emphasizes physical expression and the index emphasizes accumulated deficits, findings about mechanisms, prevalence, or treatment response should be interpreted in relation to the specific measurement approach. [7] [9]

What This Does Not Mean

Practical Interpretation Examples

Related Reading

Summary

The frailty phenotype and frailty index are complementary ways to operationalize vulnerability in ageing. The phenotype is narrower and physically grounded; the index is broader and deficit-based. Both can be useful, but their results should be interpreted according to what each model actually measures. [7] [8]

References

  1. Fried, L. P., Tangen, C. M., Walston, J. et al. "Frailty in older adults: evidence for a phenotype." Journal of Gerontology: Series A (2001), 56(3), M146-M156. https://pubmed.ncbi.nlm.nih.gov/11253156/
  2. Mitnitski, A. B., Mogilner, A. J., & Rockwood, K. "Accumulation of deficits as a proxy measure of aging." ScientificWorldJournal (2001), 1, 323-336. https://pubmed.ncbi.nlm.nih.gov/12806071/
  3. Searle, S. D., Mitnitski, A., Gahbauer, E. A., Gill, T. M., & Rockwood, K. "A standard procedure for creating a frailty index." BMC Geriatrics (2008), 8, 24. https://pmc.ncbi.nlm.nih.gov/articles/PMC2573877/
  4. Rockwood, K., & Mitnitski, A. "Frailty in relation to the accumulation of deficits." Journal of Gerontology: Series A (2007), 62(7), 722-727. https://pubmed.ncbi.nlm.nih.gov/17634318/
  5. Theou, O., Cann, L., Blodgett, J., Wallace, L. M. K., Brothers, T. D., & Rockwood, K. "Modifications to the frailty phenotype criteria: systematic review of the current literature and investigation of 262 frailty phenotypes in the Survey of Health, Ageing, and Retirement in Europe." Ageing Research Reviews (2015), 21, 78-94. https://www.sciencedirect.com/science/article/pii/S1568163715000355
  6. Kojima, G., Iliffe, S., & Walters, K. "Frailty index as a predictor of mortality: a systematic review and meta-analysis." Age and Ageing (2018), 47(2), 193-200. https://academic.oup.com/ageing/article/47/2/193/4508819
  7. Cigolle, C. T., Ofstedal, M. B., Tian, Z., & Blaum, C. S. "Comparing models of frailty: the Health and Retirement Study." Journal of the American Geriatrics Society (2009), 57(5), 830-839. https://pubmed.ncbi.nlm.nih.gov/19453306/
  8. Kim, D. J., Massa, M. S., Potter, C. M., & Clarke, R. "Systematic review of the utility of the frailty index and frailty phenotype to predict all-cause mortality in older people." Systematic Reviews (2022), 11, 187. https://pmc.ncbi.nlm.nih.gov/articles/PMC9438224/
  9. Sutton, J. L., Gould, R. L., Daley, S. et al. "Psychometric properties of multicomponent tools designed to assess frailty in older adults: a systematic review." BMC Geriatrics (2016), 16, 55. https://link.springer.com/article/10.1186/s12877-016-0225-2
Educational Disclaimer

This content is provided for educational purposes only and does not constitute medical advice.